Afsaneh Alavi, MD
Dermatology · Rochester, MNNPI 1083211023
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $63,326 of the $71,188 with a category attached, or 89.0%. It is spread thinly across 14 manufacturers, the largest accounting for just 22.7%. 2025 is the largest year on record at $27,293, 2.1 times the $12,758 reported in 2021. Among dermatology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $1369.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$16K
- Sanofi US Services Inc.$12K
- UCB, Inc.$11K
- Incyte Corporation$6K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$6K
- Boehringer Ingelheim Canada Ltd.ltee$5K
- plus $15K from 8 others
Across 40 payments — averaging $9275.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$346K
- Incyte Corporation$15K
- Boehringer Ingelheim Espana S.A.$5K
- UCB, Inc.$2K
- Novartis Pharma AG$2K
- Boehringer Ingelheim Canada Ltd.ltee$1K
What the payments were for
- Consulting fees$63,32689%
- Speaking & faculty fees$4,2756%
- Travel & lodging$2,7504%
- Food & beverage$8271%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 18 | $16,191 |
| Sanofi US Services Inc. | 1 | $11,956 |
| UCB, Inc. | 6 | $10,773 |
| Incyte Corporation | 5 | $6,438 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 | $5,851 |
| Boehringer Ingelheim Canada Ltd.ltee | 1 | $5,000 |
| Novartis | 3 | $4,179 |
| Almirall LLC | 2 | $4,000 |
| LEO Pharma AS | 1 | $3,560 |
| AbbVie | 2 | $2,800 |
| Boehringer Ingelheim | 2 | $148 |
| LEO Pharma Inc. | 3 | $130 |
| Acera Surgical, Inc. | 1 | $122 |
| Kerecis Limited | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$71,188 in reported general payments places this provider in the 95th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 14 | $792 |
| Ketoconazole | 55 | $738 |
| Metronidazole | 11 | $587 |
| Triamcinolone Acetonide | 65 | $579 |
| MethotrexateMethotrexate Sodium | 25 | $475 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $178 |
| Hydrocortisone | 17 | $59 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rochester
- Saranya WylesRochester$25K
- Nessa Aghazadeh MohandesiRochester$11K
- Alina BridgesRochester$11K
- Megha TollefsonRochester$8K
- Julia LehmanRochester$8K
- Michael WangRochester$7K
- Michael CamilleriRochester$5K
- Jennifer MartinRochester$3K
- Julio Sartori-ValinottiRochester$3K
- Ahmed AnsariRochester$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.